Published in FEMS Microbiol Lett on January 15, 2004
Specialized persister cells and the mechanism of multidrug tolerance in Escherichia coli. J Bacteriol (2004) 5.82
Staphylococcal biofilms. Curr Top Microbiol Immunol (2008) 4.26
Metabolite-enabled eradication of bacterial persisters by aminoglycosides. Nature (2011) 4.06
Persisters: a distinct physiological state of E. coli. BMC Microbiol (2006) 4.03
Activated ClpP kills persisters and eradicates a chronic biofilm infection. Nature (2013) 3.69
Platforms for antibiotic discovery. Nat Rev Drug Discov (2013) 3.66
Ciprofloxacin causes persister formation by inducing the TisB toxin in Escherichia coli. PLoS Biol (2010) 3.12
Bacterial persistence: a model of survival in changing environments. Genetics (2005) 2.97
Signaling-mediated bacterial persister formation. Nat Chem Biol (2012) 2.96
New concepts of resistance in the treatment of Helicobacter pylori infections. Nat Clin Pract Gastroenterol Hepatol (2008) 2.83
Molecular mechanisms of HipA-mediated multidrug tolerance and its neutralization by HipB. Science (2009) 2.74
Extracellular DNA chelates cations and induces antibiotic resistance in Pseudomonas aeruginosa biofilms. PLoS Pathog (2008) 2.71
Role of global regulators and nucleotide metabolism in antibiotic tolerance in Escherichia coli. Antimicrob Agents Chemother (2008) 2.40
SOS response induces persistence to fluoroquinolones in Escherichia coli. PLoS Genet (2009) 2.28
Phenotypic tolerance: antibiotic enrichment of noninherited resistance in bacterial populations. Antimicrob Agents Chemother (2005) 2.20
Increased persistence in Escherichia coli caused by controlled expression of toxins or other unrelated proteins. J Bacteriol (2006) 2.19
Candida albicans biofilms produce antifungal-tolerant persister cells. Antimicrob Agents Chemother (2006) 2.18
Ectopic overexpression of wild-type and mutant hipA genes in Escherichia coli: effects on macromolecular synthesis and persister formation. J Bacteriol (2006) 2.17
Emergence of Pseudomonas aeruginosa strains producing high levels of persister cells in patients with cystic fibrosis. J Bacteriol (2010) 2.11
Kinase activity of overexpressed HipA is required for growth arrest and multidrug tolerance in Escherichia coli. J Bacteriol (2006) 2.04
Single-cell protein induction dynamics reveals a period of vulnerability to antibiotics in persister bacteria. Proc Natl Acad Sci U S A (2008) 1.98
A dynamic and intricate regulatory network determines Pseudomonas aeruginosa virulence. Nucleic Acids Res (2012) 1.70
Bacterial plurality as a general mechanism driving persistence in chronic infections. Clin Orthop Relat Res (2005) 1.67
GlpD and PlsB participate in persister cell formation in Escherichia coli. J Bacteriol (2006) 1.66
Biofilms 2003: emerging themes and challenges in studies of surface-associated microbial life. J Bacteriol (2004) 1.65
Characterization and transcriptome analysis of Mycobacterium tuberculosis persisters. MBio (2011) 1.64
Increased antibiotic resistance of Escherichia coli in mature biofilms. Appl Environ Microbiol (2009) 1.60
Molecular basis of Staphylococcus epidermidis infections. Semin Immunopathol (2011) 1.56
Nongenetic individuality in the host-phage interaction. PLoS Biol (2008) 1.54
HipBA-promoter structures reveal the basis of heritable multidrug tolerance. Nature (2015) 1.53
Dormancy is not necessary or sufficient for bacterial persistence. Antimicrob Agents Chemother (2013) 1.51
Heterogeneous bacterial persisters and engineering approaches to eliminate them. Curr Opin Microbiol (2011) 1.47
The extracellular matrix protects Pseudomonas aeruginosa biofilms by limiting the penetration of tobramycin. Environ Microbiol (2013) 1.47
ATP-Dependent Persister Formation in Escherichia coli. MBio (2017) 1.46
Investigation of biofilm formation in clinical isolates of Staphylococcus aureus. Methods Mol Biol (2007) 1.45
Persisters, persistent infections and the Yin-Yang model. Emerg Microbes Infect (2014) 1.44
Effect of DNase and antibiotics on biofilm characteristics. Antimicrob Agents Chemother (2008) 1.42
Cell division in Escherichia coli cultures monitored at single cell resolution. BMC Microbiol (2008) 1.41
Role of oxidative stress in persister tolerance. Antimicrob Agents Chemother (2012) 1.40
Age of inoculum strongly influences persister frequency and can mask effects of mutations implicated in altered persistence. J Bacteriol (2011) 1.38
Antimicrobial peptides. Pharmaceuticals (Basel) (2013) 1.37
Microbial persistence and the road to drug resistance. Cell Host Microbe (2013) 1.37
Semimechanistic pharmacokinetic/pharmacodynamic model for assessment of activity of antibacterial agents from time-kill curve experiments. Antimicrob Agents Chemother (2006) 1.36
Pseudomonas aeruginosa increases formation of multidrug-tolerant persister cells in response to quorum-sensing signaling molecules. J Bacteriol (2010) 1.35
Effect of growth in biofilms on chlorine susceptibility of Mycobacterium avium and Mycobacterium intracellulare. Appl Environ Microbiol (2006) 1.34
Exposing plasmids as the Achilles' heel of drug-resistant bacteria. Curr Opin Chem Biol (2008) 1.34
Comparative assessment of antibiotic susceptibility of coagulase-negative staphylococci in biofilm versus planktonic culture as assessed by bacterial enumeration or rapid XTT colorimetry. J Antimicrob Chemother (2005) 1.33
Arrested protein synthesis increases persister-like cell formation. Antimicrob Agents Chemother (2013) 1.33
Bacterial persister cell formation and dormancy. Appl Environ Microbiol (2013) 1.28
Staphylococcus aureus persisters tolerant to bactericidal antibiotics. J Mol Microbiol Biotechnol (2012) 1.25
The frequency of persisters in Escherichia coli reflects the kinetics of awakening from dormancy. J Bacteriol (2010) 1.22
The three RelE homologs of Mycobacterium tuberculosis have individual, drug-specific effects on bacterial antibiotic tolerance. J Bacteriol (2010) 1.21
Increasing the duration of dual amoxicillin plus omeprazole Helicobacter pylori eradication to 6 weeks: a pilot study. J Gastroenterol Hepatol (2012) 1.20
"Persisters": survival at the cellular level. PLoS Pathog (2011) 1.19
Three Mycobacterium tuberculosis Rel toxin-antitoxin modules inhibit mycobacterial growth and are expressed in infected human macrophages. J Bacteriol (2008) 1.17
Biofilm-related infections: bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics. Microbiol Mol Biol Rev (2014) 1.16
Microbial scout hypothesis, stochastic exit from dormancy, and the nature of slow growers. Appl Environ Microbiol (2012) 1.15
Artificial activation of toxin-antitoxin systems as an antibacterial strategy. Trends Microbiol (2012) 1.15
Is bacterial persistence a social trait? PLoS One (2007) 1.14
Absence of amphotericin B-tolerant persister cells in biofilms of some Candida species. Antimicrob Agents Chemother (2008) 1.13
VapC toxins from Mycobacterium tuberculosis are ribonucleases that differentially inhibit growth and are neutralized by cognate VapB antitoxins. PLoS One (2011) 1.13
Distinguishing between resistance, tolerance and persistence to antibiotic treatment. Nat Rev Microbiol (2016) 1.12
Stochastic induction of persister cells by HipA through (p)ppGpp-mediated activation of mRNA endonucleases. Proc Natl Acad Sci U S A (2015) 1.10
Nutrient-dependent structural changes in S. aureus peptidoglycan revealed by solid-state NMR spectroscopy. Biochemistry (2012) 1.08
Borrelia burgdorferi, the Causative Agent of Lyme Disease, Forms Drug-Tolerant Persister Cells. Antimicrob Agents Chemother (2015) 1.08
The evolutionary emergence of stochastic phenotype switching in bacteria. Microb Cell Fact (2011) 1.07
Drug combinations against Borrelia burgdorferi persisters in vitro: eradication achieved by using daptomycin, cefoperazone and doxycycline. PLoS One (2015) 1.06
Pharmacodynamic modeling of ciprofloxacin resistance in Staphylococcus aureus. Antimicrob Agents Chemother (2005) 1.06
A stress-inducible quorum-sensing peptide mediates the formation of persister cells with noninherited multidrug tolerance. J Bacteriol (2012) 1.05
The fatty acid signaling molecule cis-2-decenoic acid increases metabolic activity and reverts persister cells to an antimicrobial-susceptible state. Appl Environ Microbiol (2014) 1.04
HipA-triggered growth arrest and β-lactam tolerance in Escherichia coli are mediated by RelA-dependent ppGpp synthesis. J Bacteriol (2013) 1.03
Large mutational target size for rapid emergence of bacterial persistence. Proc Natl Acad Sci U S A (2012) 1.03
Mannitol enhances antibiotic sensitivity of persister bacteria in Pseudomonas aeruginosa biofilms. PLoS One (2013) 1.02
Establishment of a method to rapidly assay bacterial persister metabolism. Antimicrob Agents Chemother (2013) 1.00
Drug resistance in eukaryotic microorganisms. Nat Microbiol (2016) 1.00
The dormant blood microbiome in chronic, inflammatory diseases. FEMS Microbiol Rev (2015) 0.99
Development of a biofilm production-deficient Escherichia coli strain as a host for biotechnological applications. Appl Environ Microbiol (2006) 0.98
Genes regulated by the Escherichia coli SOS repressor LexA exhibit heterogeneous expression. BMC Microbiol (2010) 0.98
Activity of gallidermin on Staphylococcus aureus and Staphylococcus epidermidis biofilms. Antimicrob Agents Chemother (2012) 0.96
The MerR-like transcriptional regulator BrlR contributes to Pseudomonas aeruginosa biofilm tolerance. J Bacteriol (2012) 0.96
Regulation of the Escherichia coli HipBA toxin-antitoxin system by proteolysis. PLoS One (2012) 0.96
Polymorphonuclear leukocytes restrict growth of Pseudomonas aeruginosa in the lungs of cystic fibrosis patients. Infect Immun (2014) 0.96
Control of bacterial persister cells by Trp/Arg-containing antimicrobial peptides. Appl Environ Microbiol (2011) 0.96
Exclusion rules, bottlenecks and the evolution of stochastic phenotype switching. Proc Biol Sci (2011) 0.95
New insights into the bacterial fitness-associated mechanisms revealed by the characterization of large plasmids of an avian pathogenic E. coli. PLoS One (2012) 0.95
The MerR-like regulator BrlR confers biofilm tolerance by activating multidrug efflux pumps in Pseudomonas aeruginosa biofilms. J Bacteriol (2013) 0.94
Relation between antibiotic susceptibility and ultrastructure of Staphylococcus aureus biofilms on surgical suture. Surg Infect (Larchmt) (2011) 0.94
Impact of silver-containing wound dressings on bacterial biofilm viability and susceptibility to antibiotics during prolonged treatment. Antimicrob Agents Chemother (2010) 0.94
Eradication of Pseudomonas aeruginosa biofilms by atmospheric pressure non-thermal plasma. PLoS One (2012) 0.93
Engineering persister-specific antibiotics with synergistic antimicrobial functions. ACS Nano (2014) 0.93
Inhibition of stationary phase respiration impairs persister formation in E. coli. Nat Commun (2015) 0.93
Glucose Augments Killing Efficiency of Daptomycin Challenged Staphylococcus aureus Persisters. PLoS One (2016) 0.93
Persistence of Mycoplasma hyopneumoniae in experimentally infected pigs after marbofloxacin treatment and detection of mutations in the parC gene. Antimicrob Agents Chemother (2006) 0.91
In vitro activities of different inhibitors of bacterial transcription against Staphylococcus epidermidis biofilm. Antimicrob Agents Chemother (2007) 0.91
RelE-mediated dormancy is enhanced at high cell density in Escherichia coli. J Bacteriol (2011) 0.91
Effect of farnesol on planktonic and biofilm cells of Staphylococcus epidermidis. Curr Microbiol (2009) 0.91
Metabolic aspects of bacterial persisters. Front Cell Infect Microbiol (2014) 0.91
Effective removal of staphylococcal biofilms by the endolysin LysH5. PLoS One (2014) 0.90
Antimicrobial tolerance of Pseudomonas aeruginosa biofilms is activated during an early developmental stage and requires the two-component hybrid SagS. J Bacteriol (2013) 0.90
Pathogenesis of mucosal biofilm infections: challenges and progress. Expert Rev Anti Infect Ther (2008) 0.90
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
Specialized persister cells and the mechanism of multidrug tolerance in Escherichia coli. J Bacteriol (2004) 5.82
Selective silencing of foreign DNA with low GC content by the H-NS protein in Salmonella. Science (2006) 4.60
Persisters: a distinct physiological state of E. coli. BMC Microbiol (2006) 4.03
Tackling antibiotic resistance. Nat Rev Microbiol (2011) 3.95
In silico dissection of cell-type-associated patterns of gene expression in prostate cancer. Proc Natl Acad Sci U S A (2004) 3.65
Ciprofloxacin causes persister formation by inducing the TisB toxin in Escherichia coli. PLoS Biol (2010) 3.12
Killing by bactericidal antibiotics does not depend on reactive oxygen species. Science (2013) 2.97
Stem cell-like micro-RNA signature driven by Myc in aggressive liver cancer. Proc Natl Acad Sci U S A (2010) 2.91
Molecular mechanisms of HipA-mediated multidrug tolerance and its neutralization by HipB. Science (2009) 2.74
Role of global regulators and nucleotide metabolism in antibiotic tolerance in Escherichia coli. Antimicrob Agents Chemother (2008) 2.40
Explosive spread and high prevalence of HIV infection among injecting drug users in Togliatti City, Russia. AIDS (2002) 2.40
SOS response induces persistence to fluoroquinolones in Escherichia coli. PLoS Genet (2009) 2.28
Candida albicans biofilms produce antifungal-tolerant persister cells. Antimicrob Agents Chemother (2006) 2.18
Emergence of Pseudomonas aeruginosa strains producing high levels of persister cells in patients with cystic fibrosis. J Bacteriol (2010) 2.11
Siderophores from neighboring organisms promote the growth of uncultured bacteria. Chem Biol (2010) 2.04
Kinase activity of overexpressed HipA is required for growth arrest and multidrug tolerance in Escherichia coli. J Bacteriol (2006) 2.04
Incubation of environmental samples in a diffusion chamber increases the diversity of recovered isolates. Appl Environ Microbiol (2007) 2.03
How to make the best use of intraoperative motor evoked potential monitoring? Experience in 1162 consecutive spinal deformity surgical procedures. Spine (Phila Pa 1976) (2014) 2.02
WebArray: an online platform for microarray data analysis. BMC Bioinformatics (2005) 2.01
High-throughput screen for novel antimicrobials using a whole animal infection model. ACS Chem Biol (2009) 1.99
Identification of novel antimicrobials using a live-animal infection model. Proc Natl Acad Sci U S A (2006) 1.98
Multidrug pump inhibitors uncover remarkable activity of plant antimicrobials. Antimicrob Agents Chemother (2002) 1.96
Evaluation of a modified commercial assay in detecting antibody to hepatitis C virus in oral fluids and dried blood spots. J Med Virol (2003) 1.84
Inducible expression of Tau repeat domain in cell models of tauopathy: aggregation is toxic to cells but can be reversed by inhibitor drugs. J Biol Chem (2005) 1.79
Diagnosis of prostate cancer using differentially expressed genes in stroma. Cancer Res (2011) 1.78
Genome-wide analysis of histone H3 acetylation patterns in AML identifies PRDX2 as an epigenetically silenced tumor suppressor gene. Blood (2011) 1.73
A problem of persistence: still more questions than answers? Nat Rev Microbiol (2013) 1.68
Identification of promoters bound by c-Jun/ATF2 during rapid large-scale gene activation following genotoxic stress. Mol Cell (2004) 1.67
A systematic review with meta-analysis of posterior interbody fusion versus posterolateral fusion in lumbar spondylolisthesis. Eur Spine J (2013) 1.67
GlpD and PlsB participate in persister cell formation in Escherichia coli. J Bacteriol (2006) 1.66
Characterization and transcriptome analysis of Mycobacterium tuberculosis persisters. MBio (2011) 1.64
Anthraquinones inhibit tau aggregation and dissolve Alzheimer's paired helical filaments in vitro and in cells. J Biol Chem (2004) 1.62
Killing by ampicillin and ofloxacin induces overlapping changes in Escherichia coli transcription profile. Antimicrob Agents Chemother (2004) 1.55
Patients with long-term oral carriage harbor high-persister mutants of Candida albicans. Antimicrob Agents Chemother (2009) 1.46
Cell division in Escherichia coli cultures monitored at single cell resolution. BMC Microbiol (2008) 1.41
Role of oxidative stress in persister tolerance. Antimicrob Agents Chemother (2012) 1.40
Age of inoculum strongly influences persister frequency and can mask effects of mutations implicated in altered persistence. J Bacteriol (2011) 1.38
Chromatin modifications induced by PML-RARalpha repress critical targets in leukemogenesis as analyzed by ChIP-Chip. Blood (2007) 1.28
WebArrayDB: cross-platform microarray data analysis and public data repository. Bioinformatics (2009) 1.27
Autophagic degradation of tau in primary neurons and its enhancement by trehalose. Neurobiol Aging (2011) 1.26
Staphylococcus aureus persisters tolerant to bactericidal antibiotics. J Mol Microbiol Biotechnol (2012) 1.25
Conjugating berberine to a multidrug efflux pump inhibitor creates an effective antimicrobial. ACS Chem Biol (2006) 1.24
The frequency of persisters in Escherichia coli reflects the kinetics of awakening from dormancy. J Bacteriol (2010) 1.22
Antimicrobial and efflux pump inhibitory activity of caffeoylquinic acids from Artemisia absinthium against gram-positive pathogenic bacteria. PLoS One (2011) 1.21
Evaluation of an ultrasensitive p24 antigen assay as a potential alternative to human immunodeficiency virus type 1 RNA viral load assay in resource-limited settings. J Clin Microbiol (2005) 1.21
Immobilized N-alkylated polyethylenimine avidly kills bacteria by rupturing cell membranes with no resistance developed. Biotechnol Bioeng (2005) 1.19
Interaction between cell division proteins FtsE and FtsZ. J Bacteriol (2007) 1.18
Toward an understanding of the molecular mechanism for successful blood feeding by coupling proteomics analysis with pharmacological testing of horsefly salivary glands. Mol Cell Proteomics (2007) 1.17
Polymer surfaces derivatized with poly(vinyl-N-hexylpyridinium) kill airborne and waterborne bacteria. Biotechnol Bioeng (2002) 1.14
Bactericidal properties of flat surfaces and nanoparticles derivatized with alkylated polyethylenimines. Biotechnol Prog (2002) 1.12
Isolation and physiology of bacteria from contaminated subsurface sediments. Appl Environ Microbiol (2010) 1.12
Profiling of histone H3 lysine 9 trimethylation levels predicts transcription factor activity and survival in acute myeloid leukemia. Blood (2010) 1.11
Association study of tryptophan hydroxylase 1 and arylalkylamine N-acetyltransferase polymorphisms with adolescent idiopathic scoliosis in Han Chinese. Spine (Phila Pa 1976) (2008) 1.10
Comparison of 1-stage versus 2-stage anterior and posterior spinal fusion for severe and rigid idiopathic scoliosis--a randomized prospective study. Spine (Phila Pa 1976) (2006) 1.10
Exploring molecular pathways of triple-negative breast cancer. Genes Cancer (2011) 1.10
Mechanism of bactericidal and fungicidal activities of textiles covalently modified with alkylated polyethylenimine. Biotechnol Bioeng (2003) 1.09
The Escherichia coli mqsR and ygiT genes encode a new toxin-antitoxin pair. J Bacteriol (2010) 1.06
Egr1 regulates the coordinated expression of numerous EGF receptor target genes as identified by ChIP-on-chip. Genome Biol (2008) 1.06
Cleavage of Tau by calpain in Alzheimer's disease: the quest for the toxic 17 kD fragment. Neurobiol Aging (2010) 1.05
A trap for in situ cultivation of filamentous actinobacteria. J Microbiol Methods (2008) 1.05
A new operative classification of idiopathic scoliosis: a peking union medical college method. Spine (Phila Pa 1976) (2005) 1.02
Pseudomonas aeruginosa biofilms in disease. Microb Ecol (2013) 1.02
Phenolic metabolites of Dalea versicolor that enhance antibiotic activity against model pathogenic bacteria. J Nat Prod (2004) 1.01
Synthesis of functionalized 2-aryl-5-nitro-1H-indoles and their activity as bacterial NorA efflux pump inhibitors. Bioorg Med Chem (2005) 1.00
Overexpression of BMI-1 promotes cell growth and resistance to cisplatin treatment in osteosarcoma. PLoS One (2011) 1.00
Enhancing identifications of lipid-embedded proteins by mass spectrometry for improved mapping of endothelial plasma membranes in vivo. Mol Cell Proteomics (2009) 0.99
Egr1 signaling in prostate cancer. Cancer Biol Ther (2003) 0.98
The early divisome protein FtsA interacts directly through its 1c subdomain with the cytoplasmic domain of the late divisome protein FtsN. J Bacteriol (2012) 0.97
The wisdom of the commons: ensemble tree classifiers for prostate cancer prognosis. Bioinformatics (2008) 0.97
Transcriptional cross-activation between toxin-antitoxin systems of Escherichia coli. BMC Microbiol (2013) 0.96
Two flavonols from Artemisa annua which potentiate the activity of berberine and norfloxacin against a resistant strain of Staphylococcus aureus. Planta Med (2002) 0.96
Regulation of the Escherichia coli HipBA toxin-antitoxin system by proteolysis. PLoS One (2012) 0.96
Tolerance of Escherichia coli to fluoroquinolone antibiotics depends on specific components of the SOS response pathway. Genetics (2013) 0.95
Adolescent idiopathic scoliosis and the single-nucleotide polymorphism of the growth hormone receptor and IGF-1 genes. Orthopedics (2009) 0.95
Novel high-throughput screen against Candida albicans identifies antifungal potentiators and agents effective against biofilms. J Antimicrob Chemother (2011) 0.95
Metabolites of the "smoke tree", Dalea spinosa, potentiate antibiotic activity against multidrug-resistant Staphylococcus aureus. J Nat Prod (2006) 0.95
Comparison of reliability between the PUMC and Lenke classification systems for classifying adolescent idiopathic scoliosis. Spine (Phila Pa 1976) (2008) 0.95
Antibacterial activity of berberine-NorA pump inhibitor hybrids with a methylene ether linking group. Bioorg Med Chem (2009) 0.94
Anti-thrombosis repertoire of blood-feeding horsefly salivary glands. Mol Cell Proteomics (2009) 0.94
The association analysis of TBX6 polymorphism with susceptibility to congenital scoliosis in a Chinese Han population. Spine (Phila Pa 1976) (2010) 0.93
Two immunoregulatory peptides with antioxidant activity from tick salivary glands. J Biol Chem (2010) 0.92
Structure-activity relationships of 2-aryl-1H-indole inhibitors of the NorA efflux pump in Staphylococcus aureus. Bioorg Med Chem Lett (2008) 0.91
Molecular signature and pathway analysis of human primary squamous and adenocarcinoma lung cancers. Am J Cancer Res (2011) 0.91
Dual growing rods technique for congenital scoliosis: more than 2 years outcomes: preliminary results of a single center. Spine (Phila Pa 1976) (2012) 0.90
Enhanced microarray performance using low complexity representations of the transcriptome. Nucleic Acids Res (2005) 0.90
Biorefinery products from the inulin-containing crop Jerusalem artichoke. Biotechnol Lett (2012) 0.90
Changes in HIV prevalence and risk among new injecting drug users in a Russian city of high HIV prevalence. J Acquir Immune Defic Syndr (2008) 0.88
Berberine-INF55 (5-nitro-2-phenylindole) hybrid antimicrobials: effects of varying the relative orientation of the berberine and INF55 components. Antimicrob Agents Chemother (2010) 0.88
Role of unusual P loop ejection and autophosphorylation in HipA-mediated persistence and multidrug tolerance. Cell Rep (2012) 0.87
Expression changes in the stroma of prostate cancer predict subsequent relapse. PLoS One (2012) 0.87
Persister-promoting bacterial toxin TisB produces anion-selective pores in planar lipid bilayers. FEBS Lett (2012) 0.87
Surgical treatment of metastatic spinal tumor. Chin Med Sci J (2002) 0.86
Isoflavones as potentiators of antibacterial activity. J Agric Food Chem (2003) 0.86
Lowest instrumented vertebrae selection for selective posterior fusion of moderate thoracolumbar/lumbar idiopathic scoliosis: lower-end vertebra or lower-end vertebra+1? Eur Spine J (2014) 0.85
Predictive factors of postoperative pulmonary complications in scoliotic patients with moderate or severe pulmonary dysfunction. J Spinal Disord Tech (2010) 0.84
A small trypsin inhibitor from the frog of Odorrana grahami. Biochimie (2008) 0.84